SuperworthOnconetix EPS ONCO
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- −$199.38
- Latest quarter, Q2 FY26
- −$1.28
- Fiscal year 2025
- −$2641.41
Onconetix's earnings per share was −$199.38 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$1.28.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2641.41 | n/a |
| FY2023 | −$354875.00 | n/a |
| FY2022 | −$198900.00 | n/a |
| FY2021 | −$214200.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$1.28 | n/a | −$199.38 | |
| Q1 FY26 | −$67.10 | n/a | −$436.01 | |
| Q4 FY25 | $181.50 | n/a | −$2641.41 | |
| Q3 FY25 | −$312.50 | n/a | n/a | |
| Q2 FY25 | −$237.91 | n/a | n/a | |
| Q1 FY25 | −$2272.50 | n/a | n/a | |
| Q3 FY24 | −$12454.00 | n/a | −$406656.00 | |
| Q2 FY24 | −$109579.50 | n/a | −$446094.50 | |
| Q1 FY24 | −$85340.00 | n/a | −$409615.00 | |
| Q4 FY23 | −$199282.50 | n/a | −$354875.00 | |
| Q3 FY23 | −$51892.50 | n/a | −$189592.50 | |
| Q2 FY23 | −$73100.00 | n/a | −$183600.00 |
Against its peers
Companies in Healthcare nearest Onconetix's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ONCOOnconetix | −$199.38 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Onconetix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.